Lipid-induced metabolic dysfunction in skeletal muscle

Novartis Foundation Symposium

Volumn 286, Issue , 2007, Pages 24-38

  Muoio, Deborah M ^a   Koves, Timothy R ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BIOLOGICAL MODEL; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATION REDUCTION REACTION; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION;

EID: 42449152466     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (34)

1. Adhihetty PJ, Irrcher I, Joseph AM, Ljubicic V, Hood DA 2003 Plasticity of skeletal muscle mitochondria in response to contractile activity. Exp Physiol 88:99-107
2. An J, Muoio DM, Shiota M et al 2004. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10:268-274
3. Astrup A 2001 Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr 4:499-515
4. Blaak EE 2004 Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 63:323-330
5. Bloch-Damti A, Bashan N 2005 Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal 7:1553-1567
6. Finck BN, Bernal-Mizrachi C, Han DH et al 2005 A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes. Cell Metab 1:133-144
7. Gilde AJ, Van Bilsen M 2003 Peroxisome proliferator-activated receptors (PPARs): regulators of gene expression in heart and skeletal muscle. Acta Physiol Scand 178:425-434
8. Goodpaster BH, He J, Watkins S, Kelley DE 2001 Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86:5755-61
9. Griffin ME, Marcucci MJ, Cline GW et al 1999 Free fatty acid induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270-1274
10. Guerre-Millo M, Rouault C, Poulain P et al 2001 PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50:2809-2814
11. Hirosumi J, Tuncman G, Chang L et al 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336
12. Hulver MW, Berggren JR, Cortright RN et al 2003 Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741-E747
13. Kelley DE, Goodpaster B, Wing RR, Simoneau JA 1999 Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130-E1141
14. Koves TR, Li P, An J et al 2005a Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 280:33588-33598
15. Koves TR, Noland RC, Bates AL, Henes ST, Muoio DM, Cortright RN 2005b Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism. Am J Physiol Cell Physiol 288:C1074-C1082
16. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH 1994 Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 91:10878-10882
17. Leone TC, Weinheimer CJ, Kelly DP 1999 A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96:7473-7478
18. Lin J, Wu H, Tarr PT et al 2002 Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801
19. Lowell BB, Shulman GI 2005 Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387
20. Mootha VK, Handschin C, Arlow D et al 2004 Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 101:6570-6575
21. Muoio DM, Newgard CB 2006 Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75:367-401
22. Muoio DM, MacLean PS, Lang DB et al 2002 Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice-evidence for compensatory regulation by PPAR delta. J Biol Chem 277:26089-26097
23. Perseghin G, Petersen K, Shulman GI 2003 Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 27 Suppl 3:S6-11
24. Puigserver P, Spiegelman BM 2003 Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78-90
25. Puigserver P, Wu ZD, Park CW, Graves R, Wright M, Spiegelman BM 1998 A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839
26. Randle PJ, Garland PB, Hales CN, Newsholme EA 1963 The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
27. Rosen ED, Sarraf P, Troy AE et al 1999 PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell Biol 4:611-617
28. Saha AK, Ruderman NB 2003 Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem 253:65-70
29. Saltiel AR, Pessin JE 2002 Insulin signaling pathways in time and space. Trends Cell Biol 12:65-71
30. Shoelson SE, Lee J, Yuan M 2003 Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 27 Suppl 3:S49-52
31. Shulman GI 2000 Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176
32. Sparks LM, Xie H, Koza RA et al 2005 A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54:1926-1933
33. Unger RH 2002 Lipotoxic diseases. Annu Rev Med 53:319-36
34. Yu C, Chen Y, Cline GW et al 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236